# Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU

> **NCT00307099** · PHASE3 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 460 (estimated)

## Conditions studied

- Bacterial Infection

## Interventions

- **DRUG:** Meropenem
- **DRUG:** Standard antibiotic therapy

## Key facts

- **NCT ID:** NCT00307099
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 460 (ESTIMATED)
- **Last updated:** 2013-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307099, "Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00307099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*